MedTrace Logo

Effectiveness and Acceptability of LISEFEX® (Liposomal Iron With Vitamin C and Fiber) in People With Iron Deficiency Anemia.

NCT07483645 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 74

Last updated 2026-03-19

No results posted yet for this study

Summary

Observational, descriptive, prospective, longitudinal, multicenter, non-interventionist and multicentric study in Mexican subjects diagnosed with mild to moderate iron deficiency anemia (ADH). Main objective:To evaluate the effectiveness and acceptability of LISEFEX® supplement in patients with mild to moderate iron deficiency anemia.Design The minimal risk study, no therapeutic interventions were carried out by the research team. The indication for supplementation with LISEFEX® was made by the treating physician as part of standard clinical practice, while the study was limited to systematic collection of clinical and laboratory information during participant follow-up.

Conditions

Sponsors & Collaborators

  • Carnot Laboratories

    lead INDUSTRY

Principal Investigators

  • Iris E Torres Garcia, Medico

  • Leonardo R Aguilar, Medico

  • Willy Nava, Medico

  • Edgar U Coronado, Medico

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-06
Primary Completion
2026-02-15
Completion
2026-03-30

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07483645 on ClinicalTrials.gov